Elvan Burak Verdi

Elvan Burak Verdi

Auto-generated profile, based on publicly available information

Elvan Burak Verdi

Department of Biomedical Engineering, TOBB University of Economics and Technology, Faculty of Engineering, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Tuberk Toraks
Verified
Journal Article
Closed access
AKAslıhan Gürün Kaya
Aslıhan Gürün Kaya
EVElvan Burak Verdi
Elvan Burak Verdi
SSSema Nur Süslü
Sema Nur Süslü
MKMiraç Öz Kahya
Miraç Öz Kahya
SESerhat Erol
Serhat Erol
AKAkın Kaya
Akın Kaya
Introduction: Although thorax ultrasound has been used to diagnose pneumonia in recent years, the role of ultrasonic diaphragm evaluation in the prognosis of pneumonia is unknown. This study aimed to assess the impact of diaphragmatic excursion (Dex) measured by ultrasound on the prognosis of severe pneumonia in critical care patients. Materials and Methods: We prospectively recruited patients with severe pneumonia who were admitted to the intensive care unit (ICU) between January 2019 and July 2021. Patients' Dex values, vital signs, clinical features, laboratory parameters, APACHE-II scores on the first admission day of ICU, mortality and respiratory support status at follow-up were recorded. Results: There were 39 patients enrolled in the study. Mean Dex of the study patients was 30.66 +/- 12.17 mm. Mean Dex was significantly lower in deceased patients than survivors (18.37 +/- 8.12 vs 34.90 +/- 10.36 p< 0.001). Dex was lower in patients who required invasive mechanical ventilation than those not (24.90 +/- 10.93 vs 34.26 +/- 11.70, p= 0.017). The cut-off value of Dex was found 19.0 mm for significantly predicted (p <= 0.001) survival with the sensitivity of 96.6% and specificity of 70%. Among the study group, diaphragm excursion was negatively correlated with APACHE-II score (r=-0.688, p <= 0.001) and respiratory rate (r=-0.531, p= 0.001). Conclusion: Dex measured on the day of ICU admission can be used to evaluate the prognosis of patients with severe pneumonia.

6 June 2025 in Applied Clinical Informatics
Verified
Journal Article
Closed access
PDF file
EVElvan Burak Verdi
Elvan Burak Verdi
OAOguz Akbilgic
Oguz Akbilgic
This study aimed to evaluate and compare the diagnostic responses generated by two artificial intelligence (AI) models developed 54 years apart, and encourage physicians to explore the use of large language models (LLMs) like GPT-4o in clinical practice. A clinical case of metabolic acidosis was presented to GPT-4o, and the model's diagnostic reasoning, data interpretation, and management recommendations were recorded. These outputs were then compared with the responses from Schwartz's 1970 AI model built with a decision-tree algorithm using Conversational Algebraic Language (CAL). Both models were given the same patient data to ensure a fair comparison. GPT-4o generated an advanced analysis of the patient's acid–base disturbance, correctly identifying likely causes and suggesting relevant diagnostic tests and treatments. It provided a detailed, narrative explanation of the metabolic acidosis. The 1970 CAL model, while correctly recognizing the metabolic acidosis and flagging implausible inputs, was constrained by its rule-based design. CAL offered only basic stepwise guidance and required sequential prompts for each data point, reflecting a limited capacity to handle complex or unanticipated information. GPT-4o, by contrast, integrated the data more holistically, although it occasionally ventured beyond the provided information. This comparison illustrates substantial advances in AI capabilities over five decades. GPT-4o's performance demonstrates the transformative potential of modern LLMs in clinical decision-making, showcasing abilities to synthesize complex data and assist diagnosis without specialized training, yet necessitating further validation, rigorous clinical trials, and adaptation to clinical contexts. Although innovative for its era and offering certain advantages over GPT-4o, the rule-based CAL system had technical limitations. Rather than viewing one as simply “better,” this study provides perspective on how far AI in medicine has progressed while acknowledging that current AI tools remain supplements to—not replacements for—physician judgment.

24 November 2025 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
EVElvan Burak Verdi
Elvan Burak Verdi
TATuran Acıcan
Turan Acıcan

6 January 2023 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
EVElvan Burak Verdi
Elvan Burak Verdi
MTMerve Begum Terzi
Merve Begum Terzi
DMDeniz Doğan Mülazimoğlu
Deniz Doğan Mülazimoğlu
MGMehmetcan Gök
Mehmetcan Gök
AKAslıhan Gürün Kaya
Aslıhan Gürün Kaya
ÖKÖzlem Özdemir Kumbasar
Özlem Özdemir Kumbasar
Background: During the early stages of the COVID-19 pandemic, physicians faced difficulties in radiological differential diagnosis and low sensitivity in microbiological testing. Delay in diagnosis and isolation hinders pandemic control. Artificial intelligence (AI) could help diagnose COVID-19 rapidly and accurately. We aimed to design a single AI algorithm using RT-PCR, thorax CT (TCT), and laboratory data to diagnose COVID-19 more accurately. Methods: We retrospectively created the Ankara University Faculty of Medicine COVID-19 database. Additionally, a ground-glass opacities (GGO) database was constructed for the differential diagnosis of COVID-19 pneumonia (CP). TCTs of parenchymal lung diseases with GGO involvement (PLD), non-COVID-19 viral or bacterial pneumonia with GGO (VBP), and healthy subjects (as controls) were compared. A hybrid algorithm was developed for COVID-19 diagnosis using RT-PCR curves, TCT images, and laboratory data. Findings: The TCT model diagnosed CP with >90% sensitivity and specificity. Moreover, it could distinguish between VBP and PLD with a success rate of >80%. The RT-PCR model detected COVID-19 with 96·6% sensitivity, outperforming the gold-standard RT-PCR test. The sensitivity of the hybrid model quadruple classification was 66·3%, and Cohen’s kappa was 0·75±0·02 (p<0·001). Interpretation: Although the performance scores of the TCT and RT-PCR models were high, the diagnostic success of the hybrid algorithm was lower. This is the first hybrid AI study to diagnose COVID-19 using TCT, RT-PCR, and laboratory data. This algorithm synthesises the perspectives of clinicians, radiologists, and microbiologists and has excellent potential for sharing responsibilities at critical points in medicine. Trial Registration Details: The study design has been registered at www.clinicaltrials.gov (NCT04479319). Funding Information: This study was funded by the Health Institutes of Turkey (government agency) under the Strategic Research and Development Projects Support Program [Grant No: 2020-CV-01, Project no: 9081]. Declaration of Interests: The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript. Ethics Approval Statement: The AUFM ethics committee approved the study protocol (I8-501-20). All data were anonymised.

25 March 2026 in Tuberk Toraks
Verified
Journal Article
Closed access
EVElvan Burak Verdi̇
Elvan Burak Verdi̇
The simplified pulmonary embolism severity index (sPESI) is extensively used for bedside risk assessment in acute pulmonary embolism (PE). Nevertheless, its effectiveness is constrained by the dichotomization of physiological variables and a primary validation focus on 30-day outcomes only. We developed a machine learning (ML) extension to enhance prognostic precision and extend risk stratification to 12 months, using only bedside data. In a retrospective cohort of 2547 adults with computed tomography pulmonary angiography confirmed PE, we developed logistic regression (LR), XGBoost, and multi-layer perceptron (MLP) models using a 10-item hybrid extension of sPESI that retained continuous age, heart rate, systolic blood pressure, and oxygen saturation alongside the six binary sPESI indicators. Models were trained and optimized using 12-month all-cause mortality as the target and were evaluated against 30, 180, and 365-day mortality on a held-out test set. Discrimination with the conventional sPESI attenuated over time (AUC= 0.727, 0.689, and 0.665 at 30 days, 180 days, and one year, respectively). The 10-item ML extension significantly enhanced prognostic performance compared with the conventional 6-item sPESI across all horizons (all p< 0.05). At the primary 12-month horizon, LR, XGBoost, and MLP achieved AUCs of 0.720, 0.726, and 0.712, respectively (vs. 0.665 for sPESI). At 30 days, the peak discrimination reached 0.796 (XGBoost). Moreover, ML increased 30-day specificity to 0.326-0.395 compared to 0.131 for sPESI, while maintaining high sensitivity (0.930-0.982). SHapley Additive exPlanations analyses demonstrated horizon-linked attribution shifts, with acute hemodynamic markers dominating early mortality predictions and age and malignancy emerging as the primary drivers at 12 months under horizonspecific evaluation. Preserving continuous physiological resolution within a familiar clinical framework enables ML to capture both acute instability and latent long-term vulnerability from the index presentation data alone. This bedsidefeasible pathway enhances long-horizon risk stratification and individualizes the management of patients.